So, Erdafitinib is a kind of drug. It goes after these specific changes in cancer, called FGFR2/3 alterations, especially in a type of cancer known as metastatic urothelial carcinoma. Its job is to block something called FGFR signaling.
The dosage comes in three strengths: 3 mg, 4 mg, and 5 mg film-coated tablets, with the recommended daily dose being 8 mg, adjustable up to 9 mg. This stuff comes in bottles with 56 pills each.
Reviews
There are no reviews yet.